Published in J Pain Symptom Manage on March 01, 2005
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
A systematic review of measures of end-of-life care and its outcomes. Health Serv Res (2007) 1.40
A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer (2008) 1.16
The Edmonton symptom assessment system--what do patients think? Support Care Cancer (2008) 1.14
The rapid access palliative radiotherapy program: blueprint for initiation of a one-stop multidisciplinary bone metastases clinic. Support Care Cancer (2008) 1.01
A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol (2014) 0.99
Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer (2007) 0.96
The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev (2008) 0.96
Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer (2011) 0.94
Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manag (2009) 0.94
Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage (2012) 0.88
The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: a longitudinal study. BMC Med Res Methodol (2008) 0.85
Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manag (2009) 0.81
Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag (2015) 0.80
Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors. Psychooncology (2014) 0.78
Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer. J Cancer Surviv (2014) 0.78
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief. Oncologist (2014) 0.78
Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study. J Pain Symptom Manage (2015) 0.78
Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02. J Clin Oncol (2013) 0.78
Interviews with patients with advanced cancer--another step towards an international cancer pain classification system. Support Care Cancer (2012) 0.76
Neuropathic pain: a personal case reflection on a critical incident. Indian J Palliat Care (2011) 0.76
Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience. Support Care Cancer (2012) 0.75
Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results. Support Care Cancer (2013) 0.75
Use of an abbreviated form of the Edmonton staging system in a hospice setting. J Pain Symptom Manage (2006) 0.75
Characteristics and prognostic factors for pain management in 152 patients with lung cancer. Patient Prefer Adherence (2016) 0.75
Promoting science in a pragmatic world: not (yet) time for partial opioid rotation. Support Care Cancer (2005) 0.75
Assessing the prognostic features of a pain classification system in advanced cancer patients. Support Care Cancer (2017) 0.75
Modern pain neuroscience in clinical practice: applied to post-cancer, paediatric and sports-related pain. Braz J Phys Ther (2017) 0.75
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol (2009) 4.66
Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol (2011) 3.75
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol (2006) 2.51
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer (2006) 1.75
Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer (2007) 1.68
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis. Am J Gastroenterol (2002) 1.60
An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer (2010) 1.59
Dosimetric consequences of increased seed strength for I-125 prostate implants. Radiother Oncol (2003) 1.39
Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiother Oncol (2011) 1.28
Predicting survival in patients with advanced disease. Eur J Cancer (2008) 1.26
Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res (2006) 1.24
Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.24
The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial. Breast Cancer Res Treat (2004) 1.22
What procedures are students doing during undergraduate surgical clerkship? Can J Surg (2006) 1.21
A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med (2005) 1.18
The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology (2011) 1.18
A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer (2008) 1.16
Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res (2005) 1.09
Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. Cancer Chemother Pharmacol (2006) 1.09
Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy. Am J Clin Oncol (2007) 1.09
Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol (2008) 1.08
Evaluation of a data collection tool (TELEform) for palliative care research. J Palliat Med (2003) 1.08
Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol (2002) 1.05
Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab (2008) 1.02
Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg (2004) 1.00
Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care (2009) 1.00
Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care (2005) 0.99
The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Res Treat (2010) 0.99
Skin-sparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: a planning study. Int J Radiat Oncol Biol Phys (2007) 0.97
Purification and characterization of a recombinant G-protein-coupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK293 EBNA1 cells. Biochemistry (2005) 0.96
Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer (2007) 0.96
Hand-held dynamometry: tester strength is paramount, even in frail populations. J Rehabil Med (2011) 0.95
Improving access to specialist multidisciplinary palliative care consultation for rural cancer patients by videoconferencing: report of a pilot project. Support Care Cancer (2012) 0.95
A phase II trial of Reiki for the management of pain in advanced cancer patients. J Pain Symptom Manage (2003) 0.94
Prospective study of falls and risk factors for falls in adults with advanced cancer. J Clin Oncol (2012) 0.93
Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle (2010) 0.93
Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma. Mod Pathol (2005) 0.93
Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr (2011) 0.90
A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg (2003) 0.89
P-selectin genotype is associated with the development of cancer cachexia. EMBO Mol Med (2012) 0.89
Induced hypotension with epidural/general anesthesia reduces transfusion in radical prostate surgery. Can J Anaesth (2006) 0.87
Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer. Clin Colorectal Cancer (2008) 0.87
Should the rate of opioid dose escalation be included as a feature in a cancer pain classification system? J Pain Symptom Manage (2007) 0.87
Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. J Pain Symptom Manage (2003) 0.87
Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Can J Gastroenterol (2007) 0.87
Palliative radiotherapy for patients with bone metastases: survey of primary care physicians. Radiother Oncol (2003) 0.86
Ageism in rectal carcinoma? Treatment and outcome variations. Int J Gastrointest Cancer (2002) 0.86
The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: a longitudinal study. BMC Med Res Methodol (2008) 0.85
Cancer pain assessment--can we predict the need for specialist input? Eur J Cancer (2008) 0.85
Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol (2003) 0.85
Genetic predisposition to the cytotoxicity of arsenic: the role of DNA damage and ATM. FASEB J (2003) 0.85
Breast radiotherapy with inclusion of internal mammary nodes: a comparison of techniques with three-dimensional planning. Int J Radiat Oncol Biol Phys (2003) 0.83
Meeting the family: measuring effectiveness of family meetings in a specialist inpatient palliative care unit. Palliat Support Care (2012) 0.83
The role of antibiotics in the management of infection-related symptoms in advanced cancer patients. J Palliat Care (2006) 0.83
Determining the precision of dual energy x-ray absorptiometry and bioelectric impedance spectroscopy in the assessment of breast cancer-related lymphedema. Lymphat Res Biol (2013) 0.82
Palliative care nurses' perceptions of the Edmonton Symptom Assessment Scale: a pilot survey. Int J Palliat Nurs (2006) 0.82
Double gloving and practice attitudes among surgeons. Am J Surg (2003) 0.82
Uptake of heavy metals by some edible vegetables irrigated using wastewater: a preliminary study in Accra, Ghana. Environ Monit Assess (2013) 0.81
Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag (2015) 0.80
Autonomic dysfunction in patients with advanced cancer; prevalence, clinical correlates and challenges in assessment. BMC Palliat Care (2012) 0.80
Vitamin D depletion: of clinical significance in advanced cancer? Support Care Cancer (2011) 0.80
Perceptions of conflict of interest: surgeons, internists, and learners compared. Am J Surg (2013) 0.80
Development of a new equation to estimate creatinine clearance in cancer patients. Cancer Chemother Pharmacol (2015) 0.80
How to identify patients with cancer at risk of falling: a review of the evidence. J Palliat Med (2011) 0.79
mtDNA mutations in invasive cervix tumors: a retrospective analysis. Cancer Lett (2006) 0.79
Combination surgical and mechanical therapy for refractory cases of obstructive sleep apnea. J Otolaryngol (2002) 0.79
Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung. Radiother Oncol (2010) 0.79
A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manage (2011) 0.78
Exploring the links between depression, integrity, and hope in the elderly. Can J Psychiatry (2004) 0.78
Palliative care providers' opinions of the edmonton symptom assessment system revised (ESAS-r) in clinical practice. J Pain Symptom Manage (2012) 0.78
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. J Palliat Med (2008) 0.78
Delirium masquerading as depression. Palliat Support Care (2012) 0.77
Metabolic, nutritional and inflammatory characteristics in elderly women with advanced cancer. J Geriatr Oncol (2012) 0.77
Defining and managing biohazardous waste in U.S. research-oriented universities: a survey of environmental health and safety professionals. J Environ Health (2003) 0.76
Treatment of nasopharyngeal carcinoma in the modern era: analysis of outcomes and toxicity from a single center in a nonendemic area. Cancer J (2006) 0.76
Determination of some heavy metal levels in soft drinks on the Ghanaian market using atomic absorption spectrometry method. Environ Monit Assess (2014) 0.75
Assessing the reliability and validity of the revised WCCNR stomatitis staging system for cancer therapy-induced stomatitis. Can Oncol Nurs J (2004) 0.75
Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 0.75
Emerging technologies in surgical planning for breast cancer. Am J Surg (2002) 0.75
Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs (2004) 0.75
Deep vein thrombosis (DVT) in advanced cancer patients with lower extremity edema referred for assessment. Am J Hosp Palliat Care (2005) 0.75
Cancer pain: progress and ongoing issues in Ireland. Pain Res Manag (2009) 0.75